Home > Income Statement > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Consolidated Net Profit

    Back to Income Statement
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹9.49 Cr₹15 Cr₹15 Cr₹1,212,944 Cr₹13 Cr

What is the latest Consolidated Net Profit of MEDICAMEN BIOTECH ?

The latest Consolidated Net Profit ratio of MEDICAMEN BIOTECH is ₹9.49 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹9.49 Cr
Mar2024₹15 Cr
Mar2023₹15 Cr
Mar2022₹1,212,944 Cr
Mar2021₹13 Cr

How is Consolidated Net Profit of MEDICAMEN BIOTECH Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹9.49 Cr
-35.54
Mar2024 ₹15 Cr
-1.13
Mar2023 ₹15 Cr
-100.00
Mar2022 ₹1,212,944 Cr
9,125,955.15
Mar2021 ₹13 Cr -

Compare Consolidated Net Profit of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹433.9 Cr 1.5% 32.8% -7.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹444,717.0 Cr -0.8% -2.5% 11.9% Stock Analytics
DIVIS LABORATORIES ₹255,115.0 Cr 1.9% 6.6% 55.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,613.0 Cr 0.3% 2% 35.9% Stock Analytics
CIPLA ₹112,876.0 Cr 0.9% -0.8% -10.9% Stock Analytics
DR REDDYS LABORATORIES ₹100,395.0 Cr 0.1% 1.4% -9.3% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

1.5%

32.8%

-7.5%

SENSEX

-0.5%

-4.8%

-11%


You may also like the below Video Courses